Opinion

Video

Atopic Dermatitis: Topical Therapies and Unmet Needs in the Treatment Landscape

Key opinion leaders provide a concise overview of the atopic dermatitis (AD) treatment landscape, focusing on the role of topical therapy, and highlight the current unmet needs in AD management.

  1. Provide a brief overview of the treatment landscape, and where topical therapies and systemic therapies fit into this landscape. What are the current unmet needs from your perspective?
  2. Please incorporate a discussion of the following topical therapies:
  3. Corticosteroids
  4. Crisaborole – AD-301/AD-302, CrisADe CARE 1 
  5. Ruxolitinib – TRuE-AD1/TRuE-AD2 – original publication, long-term follow up
Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo